Safety and effectiveness of a somatropin biosimilar in children requiring growth hormone treatment: second analysis of the PATRO Children study Italian cohort.
Lorenzo LughettiF AntoniazziC GiavoliG BonaT AversaN A GreggioL GuazzarottiR MinelliL PerroneL PersaniG PozzobonL RagusaS StagiG TorneseC ZecchinoP GallinariH ZouaterP FedeliS ZucchiniPublished in: Journal of endocrinological investigation (2020)
In this sub-analysis of PATRO Children, Omnitrope® appeared to have acceptable safety and effectiveness in the treatment of in Italian children, which was consistent with the earlier findings from controlled clinical trials.